MGC PHARMACEUTICALS
MGC Pharmaceuticals Ltd. is an Australian Company publicly listed on the ASX (ASX:MXC) founded in early 2015 by leading Israeli medical cannabis industry executives. The goal was establishing a global cannabinoid (CBD) and medical cannabis business utilizing their intellectual property, expertise and contacts, with a focus on the CBD market in Europe and Australia. MGC is operates globally with an agenda of adding value to the whole product chain, from growing and breeding unique strains to developing medicine delivery systems. With the Medical Cannabis industry, and particularly the CBD subsection of this industry booming globally, now is a time where making correct choices in partnerships and associations becomes most crucial.
MGC PHARMACEUTICALS
Industry:
Cannabis Clinical Trials Cosmetics Pharmaceutical
Founded:
2005-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.mgcpharma.com.au
Total Employee:
11+
Status:
Active
Contact:
+61893892000
Email Addresses:
[email protected]
Total Funding:
18.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins Sitelinks Search Box Euro
Similar Organizations
Ceva Santรฉ Animale
Ceva Sante Animale is a veterinary health company focused on the research, development, production and marketing of pharmaceutical products.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Stock Details
Investors List
Malta Enterprise
Malta Enterprise investment in Grant - MGC Pharmaceuticals
Official Site Inspections
http://www.mgcpharma.com.au Semrush global rank: 9.77 M Semrush visits lastest month: 112
- Host name: 178.62.115.53
- IP address: 178.62.115.53
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "MGC Pharmaceuticals" on Search Engine
MGC Pharma Rebrands as Argent BioPharma in Strategic โฆ
Feb 13, 2024 Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and Nanotechnology.See details»
MGC Pharmaceuticals - Crunchbase Company Profile & Funding
MGC Pharmaceuticals Ltd. is an Australian Company publicly listed on the ASX (ASX:MXC) founded in early 2015 by leading Israeli medical cannabis industry executives.See details»
MGC Pharma Rebrands as Argent BioPharma in Strategic
Feb 13, 2024 As Argent BioPharma transitions from MGC Pharma, it stands ready to lead a new era in biopharmaceuticals, promising accessible and impactful healthcare โฆSee details»
MGC Pharma Rebrands as Argent BioPharma in Strategic
LONDON, Feb. 13, 2024 /PRNewswire/ -- MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC) Rebrands as Argent BioPharma in Strategic Transformation. โฆSee details»
MGC Pharmaceuticals secures funding through to the end of 2024
Nov 1, 2023 MGC aims to progress its leading drugs, CannEpil and CimetrA, toward FDA approval and expand its medicinal footprint via early patient access schemes in the UK, โฆSee details»
MGC Pharma: Pushing the envelope of โฆ
Apr 11, 2019 MGC Pharmaceuticals (ASX: MXC; OTC:MGCLF) is at the forefront of the shift โ bringing together the scientific world of pharma with the holistic and long-acknowledged benefits of phytocannabinoids to an โฆSee details»
MGC Pharmaceuticals rebrands as Argent BioPharma in โฆ
MGC Pharmaceuticals has officially rebranded to Argent BioPharma. Strategic renaming follows infusion of capital and an operational overhaul. Company looking to establish โฆSee details»
MGC Pharmaceuticals Company Profile - Craft
Apr 24, 2024 Overview. MGC Pharmaceuticals is a biopharma company focusing on the cannabinoid (CBD) and medical cannabis business. It supplies GMP (good โฆSee details»
MGC Pharmaceuticals - Recent News & Activity - Crunchbase
Feb 19, 2024 Recent News & Activity. Business of Cannabis โ MGC Pharma & Hellenic Dynamics Both Turn to Share Consolidation as They Secure New Funding, Stenocare ...See details»
Punching the lights out: Best half year ever for MGC Pharma as it ...
Mar 2, 2022 MGC Pharma has just delivered its best half ever, as it looks to complete a pipeline of clinical trials and convert them into commercial contracts. The half saw MGC โฆSee details»
MGC Pharmaceuticals reveals strategic objectives for H1 2024, โฆ
(NewsDirect) MGC Pharmaceuticals Ltd CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share โฆSee details»
MGC Pharmaceuticals "pushing on" after announcing fresh $1mln โฆ
Jul 11, 2023 MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Thomas Warner from Proactive after the โฆSee details»
MGC
A next-generation pharmaceutical company.See details»
MGC Pharmaceuticals Limited - AnnualReports.com
MGC Pharmaceuticals Ltd (ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines โฆSee details»
MGC Pharmaceuticals - Funding, Financials, Valuation & Investors
MGC Pharmaceuticals is a company founded with vision. A vision of globalizing the arena in which Cannabis, and specifically CBD.See details»
MGC Pharmaceuticals to "move forward and speak to the FDA"
Aug 14, 2023 MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) CEO and managing director Roby Zomer speaks to Thomas Warner from Proactive after the โฆSee details»
โFully fundedโ โ MGC Pharma completes share consolidation and โฆ
Nov 10, 2023 MGC Pharmaceuticals completes share consolidation, ~US$8 million capital raise. Company says itโs fully funded and well-positioned to proceed with โฆSee details»
MGC Pharmaceuticals clarifies share consolidation and new โฆ
Nov 2, 2023 MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has provided clarity on the companyโs consolidation of capital and new fundraising programme.See details»
MGC Pharmaceuticals to "move forward and speak to the FDA", โฆ
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) CEO and managing director Roby Zomer speaks to Thomas Warner from Proactive after the Europe-based โฆSee details»
MGC Pharmaceuticals - Contacts, Employees, Board Members, โฆ
MGC Pharmaceuticals is a company founded with vision. A vision of globalizing the arena in which Cannabis, and specifically CBD.See details»